RULE NO.:RULE TITLE:
64B13-18.003Procedures Regarding Topical Ocular Pharmaceutical Agents
NOTICE OF CHANGE
Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 39, No. 196, October 8, 2013 issue of the Florida Administrative Register.
The change is in response to comments submitted by the Joint Administrative Procedures Committee in a letter dated October 2, 2013. The changes are as follows:
Rule 64B13-18.003 will read as:
(Substantial rewording of the Rule 64B13-18.003 follows. See Florida Administrative Code for the current text)
64B13-18.003 Procedures Regarding Topical Ocular Pharmaceutical Agents.
(1) Requests for the addition, deletion or modification of the formulary of topical ocular pharmaceutical agents shall be filed with the Board. The request shall be in writing and shall contain the following information:
(a) The name, address, and telephone number of the individual or entity filing the request;
(b) The chemical name of the agent;
(c) The brand name(s) of the agent;
(d) The concentration of the agent;
(e) The United States FDA approved information sheet for the agent;
(f) The date the FDA released the agent for sale; and
(g) An explanation why the requested addition, deletion or modification is consistent with the provisions of Section 463.0055, F.S. and should be made.
(2) A current list of all topical ocular pharmaceutical agents which certified optometrists are authorized to prescribe or administer shall be maintained by the Board and shall be available upon request.
Rulemaking Authority 463.005, 463.0055(2)(a) FS. Law Implemented 463.0055 FS. History–New 5-15-97, Formerly 59V-18.003, Amended__________.
The person to be contacted regarding the above change is: William Miller, Executive Director, Board of Optometry, 4052 Bald Cypress Way, Bin C07, Tallahassee, Florida 32399-3257
Document Information
- Related Rules: (1)
- 64B13-18.003. Procedures Regarding Topical Ocular Pharmaceutical Agents